Today we'll evaluate Natural Alternatives International, Inc. (NASDAQ:NAII) to determine whether it could have...
LAS VEGAS , Oct. 16, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), the company behind SR CarnoSyn®, a patented, sustained-release version of beta-alanine, ...
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll apply a...
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Natural Alternatives International, Inc. (NASDAQ: NAII).
Mark LeDoux has been the CEO of Natural Alternatives International, Inc. (NASDAQ:NAII) since 1986. This analysis aims...
CARLSBAD, Calif., May 14, 2020 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.0 million, or $0.61 per dil…
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.0 million, or $0.61 per diluted share, for the quarter ended March 31, 202…
Today we'll evaluate Natural Alternatives International, Inc. (NASDAQ:NAII) to determine whether it could have...
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), the company behind SR CarnoSyn®, a patented, sustained-release beta-alanine, will exhibit at the Integrative Healthcare Symposium (IHS) Annual Conference in New York, NY on February 20-22, 2020 at the New York Hilton Midtown. The CarnoSyn® Brands team will present the latest clinical research on their groundbreaking ingredient solution for healthy aging and everyday wellness during a luncheon session on Friday, February 21st.
CARLSBAD, Calif. , Nov. 14, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, ...
CarnoSyn® Brands, a division of Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), and one of the world's leading sports performance ingredients, has partnered with TEST Football Academy for the third year in a row to fuel NFL hopefuls in their preparation for the combine and their respective collegiate pro days. Several new Team CarnoSyn® athletes made their mark at the 2020 NFL Scouting Combine.
NEW YORK, April 06, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Natural Alternatives.
- Fiscal Year 2019 Sales of $138.3 million - Fiscal Year 2019 Net Income of $6.5 million and $0.92 in Diluted EPS CARLSBAD, Calif. , Sept. 24, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ...
CARLSBAD, Calif., May 14, 2020 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.0 million, or $0.61 per dil…
CARLSBAD, Calif., Sept. 17, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NAII) today proudly announces its CarnoSyn® beta-alanine has received the coveted Novel Ingredient and Science Award from the Natural Products Association (NPA) at their annual conference, The Big Natural, in Washington, D.C., held September 11-12, 2019. The Novel Ingredient and Science Award is bestowed annually upon a person or company who has developed an innovative ingredient with far reaching applications, clinical disease utility, health benefit, or regulatory safety achievement, demonstrated through sound scientific research. The NPA recognizes NAI for its leadership in the industry, commitment to innovation, research and performance, and its perseverance to go above and beyond—achieving New Dietary Ingredient (NDI) status from the FDA for CarnoSyn® beta-alanine.
It hasn't been the best quarter for Natural Alternatives International, Inc. (NASDAQ:NAII) shareholders, since the...
MANILA (UPDATED) -- Comedy superstar Vice Ganda on Friday night hosted an interactive online game show on Facebook amid the novel coronavirus pandemic.
NEW YORK, NY / ACCESSWIRE / April 7, 2020 / Levi & Korsinsky announces it has commenced an investigation of Natural Alternatives International, Inc. (NASDAQ:NAII) concerning possible breaches of fiduciary ...
If you want to know who really controls Natural Alternatives International, Inc. (NASDAQ:NAII), then you'll have to...
Mark LeDoux became the CEO of Natural Alternatives International, Inc. (NASDAQ:NAII) in 1986. First, this article will...
TUCSON, Ariz. , Nov. 6, 2019 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), the company behind SR CarnoSyn ® , a patented, sustained-release version of CarnoSyn ...
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced its Board of Directors authorized a $1.0 million increase to its stock repurchase plan bringing the total plan authorized repurchase amount to $10.0 million. Under the repurchase plan, NAI may, from time to time, purchase shares of its common stock, depending upon market conditions, in open market or privately negotiated transactions. Since December 31, 2019, we have purchased an additional 198,336 shares of our common stock under this plan bringing our total plan purchases to date to 1.2 million shares. At present there is $2.0 million remaining available for stock repurchases under the plan.
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.0 million, or $0.61 per diluted share, for the quarter ended March 31, 2020.
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced net income of $476,000, or $0.07 per diluted share.